Healthcare provider profile · identity verified

Steven David Weiss, MD

Internal Medicine · EAU CLAIRE, WI · NPI 1619957891

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	385	110
Lisinopril	Lisinopril	253	74
Amlodipine Besylate	Amlodipine Besylate	199	60
Hydrochlorothiazide	Hydrochlorothiazide	182	64
Omeprazole	Omeprazole	181	57
Metoprolol Succinate	Metoprolol Succinate	159	48
Gabapentin	Gabapentin	158	40
Losartan Potassium	Losartan Potassium	146	44
Tamsulosin Hcl	Tamsulosin Hcl	146	38
Furosemide	Furosemide	145	45
Albuterol Sulfate Hfa	Albuterol Sulfate	140	39
Levothyroxine Sodium	Levothyroxine Sodium	127	38
Eliquis	Apixaban	108	26
Metoprolol Tartrate	Metoprolol Tartrate	105	35
Ozempic	Semaglutide	103	20
Tramadol Hcl	Tramadol Hcl	102	27
Trazodone Hcl	Trazodone Hcl	90	21
Sertraline Hcl	Sertraline Hcl	89	25
Trulicity	Dulaglutide	88	18
Warfarin Sodium	Warfarin Sodium	83	22
Metformin Hcl	Metformin Hcl	79	23
Pantoprazole Sodium	Pantoprazole Sodium	78	25
Rosuvastatin Calcium	Rosuvastatin Calcium	78	26
Potassium Chloride	Potassium Chloride	76	25
Simvastatin	Simvastatin	68	22
Lorazepam	Lorazepam	66	15
Spironolactone	Spironolactone	64	17
Pravastatin Sodium	Pravastatin Sodium	63	18
Fluoxetine Hcl	Fluoxetine Hcl	61	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	24
Carvedilol	Carvedilol	56	15
Metformin Hcl Er	Metformin Hcl	56	20
Fluticasone Propionate	Fluticasone Propionate	55	21
Atenolol	Atenolol	52	14
Prednisone	Prednisone	52	29
Mirtazapine	Mirtazapine	51	11
Baclofen	Baclofen	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	17
Alendronate Sodium	Alendronate Sodium	46	17
Allopurinol	Allopurinol	46	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	11
Alprazolam	Alprazolam	40	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Myrbetriq	Mirabegron	39	suppressed
Famotidine	Famotidine	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Ezetimibe	Ezetimibe	36	12
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	23
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Glimepiride	Glimepiride	32	suppressed
Glipizide	Glipizide	32	11
Incruse Ellipta	Umeclidinium Bromide	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Clonazepam	Clonazepam	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Spiriva Handihaler	Tiotropium Bromide	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Finasteride	Finasteride	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Amoxicillin	Amoxicillin	23	18
Azithromycin	Azithromycin	23	22
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Nitroglycerin	Nitroglycerin	22	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Varenicline Tartrate	Varenicline Tartrate	22	12
Xarelto	Rivaroxaban	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Insulin Aspart Flexpen	Insulin Aspart	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Linzess	Linaclotide	19	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Levofloxacin	Levofloxacin	17	13
Montelukast Sodium	Montelukast Sodium	17	suppressed
Nystatin	Nystatin	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Torsemide	Torsemide	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Colchicine	Colchicine	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Metolazone	Metolazone	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error